TRANSDERMALES PFLASTER MIT RIVASTIGMIN

Patent europeic · EP3501518 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3501518
Numer da la dumonda
EP17843502
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-08-2017
Publitgà
26-06-2019
Concedì
14-05-2025
La protecziun finescha il pli tard
20-08-2037
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 9/70 (2006.01)
A61K 47/12 (2006.01)
A61K 31/27 (2006.01)
A61K 31/202 (2006.01)
A61P 25/28 (2006.01)
Prioritad
JP 2016161730 22.08.2016
Dumonda PCT
PCT/JP2017/029697 21.08.2017
Publicaziun PCT
WO2018/038022 01.03.2018
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 25-03-2026

    Midada

    Published in Swissreg on 25.03.2026

  3. 01-09-2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  4. 23-05-2025

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 23.05.2025

  5. 14-05-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.05.2025

Partidas

Inventur

FUTATSUYA, Akihiro

Imizu-shi Toyama 939-0351, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.